Topics
Glioblastoma | Treatment | Clinical trials | Bevacizumab
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Bevacizumab
Tanaka T, Tamura R, Takei J, Morimoto Y, Teshigawara A, Yamamoto
Y, Imai R, Kuranari Y, Tohmoto K, Hasegawa Y, Akasaki Y, Murayama
Y, Miyake K, Sasaki H.
An exploratory
prospective phase II study of preoperative neoadjuvant bevacizumab
and temozolomide for newly diagnosed glioblastoma.
J
Neurooncol. 2024 Jan 31. doi:
10.1007/s11060-023-04544-8. PMID:
38291182. Interventional
study. ˍ
Motamed-Sanaye A, Mortezaei A, Afshari AR, Saadatian Z, Faraji AH,
Sheehan JP, Mokhtari AM.
Angiogenesis
inhibitors effects on overall survival and
progression-free survival in newly
diagnosed primary glioblastoma multiforme: a
meta-analysis of twelve randomized
clinical trials.
J
Neurooncol. 2024 Dec 5. doi:
10.1007/s11060-024-04865-2. PMID:
39636552. Meta-analysis˰
ˍ